Patent: 5,689,046
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 5,689,046
| Title: | Stilbene synthase gene |
| Abstract: | A stilbene synthase gene. More particularly, a stilbene synthase gene in which the stilbene synthase is resveratrol synthase. Also more particularly a stilbene synthase gene which is obtained from groundnut (Arachis hypogaea). Furthermore a stilbene synthase gene, corresponding to the stilbene synthase gene which is contained in the plasmid pGS 828.1, and DNA sequences acting in essentially the same say. Still further, a stilbene synthase gene unit which comprises approximately 6,700 base pairs and exhibits 3 EcoRI, 3 HindIII and 1 PstI cleavage sites, and which can be obtained by partial cleavage of the plasmid PGS 828.1 using EcoRI and HindIII, or from plasmid pGS 828.1 using SstI and PvuII. |
| Inventor(s): | Schroder; Gudrun (Gundelfingen, DE), Schroder; Joachim (Gundelfingen, DE), Hain; Rudiger (Langenfeld, DE), Schreier; Peter Helmut (Cologne, DE) |
| Assignee: | Bayer Aktiengesellschaft (Leverkusen, DE) |
| Application Number: | 08/461,901 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,689,046
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2014-11-18 |
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2014-11-18 | |
| Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2014-11-18 | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
